Gastrointestinal symptoms under opioid therapy: A prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine-Reference-Cited by-同舟云学术

Gastrointestinal symptoms under opioid therapy: A prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine

Published:2009-08 Issue:7 Volume:13 Page:737-743
ISSN:1090-3801
Container-title:European Journal of Pain
language:en
Short-container-title:

Author:

Wirz Stefan,Wittmann Maria,Schenk Michael,Schroeck Andreas,Schaefer Nico,Mueller Marcus,Standop Jens,Kloecker Norbert,Nadstawek Joachim

Publisher

Wiley

Subject

Anesthesiology and Pain Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.ejpain.2008.09.005/fullpdf

Reference47 articles.

1. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology;Aaronson;J Nat Cancer Inst,1993

2. A constipation scoring system to simplify evaluation and management of constipated patients;Agachan;Dis Colon Rectum,1996

3. On behalf of the TTS-Fentanyl Comparative Trial Group. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life;Ahmedzai;J Pain Symptom Manage,1997

4. Factors influencing constipation in advanced cancer patients: a prospective study of opioid dose, dantron dose and physical functioning;Bennett;Palliative Med,2003

5. The edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients;Bruera;J Palliative Care,1991

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naldemedine is associated with earlier defecation in critically ill patients with opioid-induced constipation: A retrospective, single-center cohort study;PLOS ONE;2024-01-03

2. Opioid analgesics for nociceptive cancer pain: A comprehensive review;CA: A Cancer Journal for Clinicians;2023-12-18

3. Survey of Prophylactic Administration of Naldemedine for Opioid-induced Constipation;YAKUGAKU ZASSHI;2023-02-01

4. Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019;Zeitschrift für Gastroenterologie;2022-10

5. Revision of Pharmacological Treatment Recommendations for Cancer Pain: Clinical Guidelines from the Japanese Society of Palliative Medicine;Journal of Palliative Medicine;2022-07-01